Why patients are searching for MEDVi alternatives
MEDVi grew from zero to over 500,000 patients in under two years. That growth came with serious problems that became public in 2025 and 2026. Here are the documented reasons patients are now actively looking for alternatives.
Patient data breach
OpenLoop Health — MEDVi's clinical partner — suffered a breach in January 2026 exposing 1.6 million patient records including medical information.
Warning letter issued
The FDA issued MEDVi a warning letter in February 2026 for misleading advertising claims about compounded GLP-1 medications.
Federal lawsuit
A federal class action complaint filed in November 2025 alleges MEDVi sold ineffective compounded oral tirzepatide as "modern-day snake oil."
BBB rating
MEDVi has an F rating from the Better Business Bureau with 361 filed complaints — primarily for billing issues and cancellation difficulty.
Spanish support
MEDVi is English-only. 65 million US Hispanic adults have no bilingual GLP-1 telehealth option — until now.
Fake photos
Futurism reported that MEDVi used AI-generated deepfake before/after photos in their marketing materials.
What to look for in a MEDVi alternative
Not all GLP-1 telehealth platforms are the same. When evaluating a MEDVi alternative, these are the factors that matter most:
- Data security: Does the platform use clinical partners with a clean security record? Has there been a breach?
- Regulatory status: Is the platform LegitScript certified? Have they received FDA warning letters?
- Pricing transparency: Is the advertised price truly all-inclusive, or are there hidden fees, separate membership charges, or bait-and-switch intro pricing?
- Cancellation policy: Can you cancel easily? Is there a one-click option or do you have to email and wait?
- Language support: If you speak Spanish or are researching for a family member, does the platform serve you?
- Human support: Can you reach a real person? How long does it take to get a response?
- Women's health: If you want HRT, hair, or skin care alongside GLP-1, does the platform offer it?
The top MEDVi alternatives in 2026
all-inclusive
semaglutide
per month
The gap none of them fill — except REMEVi
Here is the fact that no comparison article mentions: every single MEDVi alternative on every existing list — Hims, Ro, LifeMD, Henry Meds — is English only.
There are 65 million Spanish-speaking adults in the United States. The adult obesity rate among Hispanic Americans is approximately 45.6% — among the highest of any demographic group. Less than 10% have ever used a prescription weight loss medication. The reason is not lack of interest. It is lack of access to healthcare that speaks their language.
REMEVi exists to close that gap. We are the only GLP-1 telehealth platform that a Spanish-speaking patient can use entirely in their own language — from the first intake question to the last support message.
Start in English
Bilingual care. Transparent pricing. No data breaches. Starting $169/mo.
Get started →Empieza en español
La primera plataforma GLP-1 completamente bilingüe. Desde $169/mes.
Empieza aquí →How to switch from MEDVi to REMEVi
Switching GLP-1 platforms is straightforward. Here is how to do it without interrupting your treatment:
- Don't stop your medication abruptly. Time your switch so your last MEDVi shipment overlaps with your REMEVi approval window.
- Cancel MEDVi before your next billing date. Based on customer reviews, the most reliable cancellation method is MEDVi's in-portal chat support. Email also works but takes longer. Keep a screenshot of your cancellation confirmation.
- Start your REMEVi intake. During the intake questionnaire, note your current GLP-1 medication and dosage. Our clinical partner's physicians will review this and maintain your dosing continuity where appropriate.
- Choose your language preference. At intake, select English or Spanish. Every communication from that point will be in your chosen language.
- Expect approval within 24–48 hours. After your intake is reviewed by a licensed physician, your prescription is sent to our pharmacy partner for fulfillment.
Frequently asked questions about MEDVi alternatives
The MEDVi alternative you've been looking for.
Bilingual. Trustworthy. All-inclusive from $169/month. No data breaches. No FDA warnings. Real humans.
Start with REMEVi today →Disclaimer: This guide is based on publicly available information, BBB records, FDA public filings, court documents, and verified customer reviews as of April 2026. REMEVi is not affiliated with MEDVi, Hims & Hers, Ro, or their partners. All pricing and comparative claims should be independently verified. This content is for informational purposes only and does not constitute medical advice. GLP-1 medications require evaluation by a licensed healthcare provider.